Market Cap 10.25B
Revenue (ttm) 3.24B
Net Income (ttm) -3.56B
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -110.04%
Debt to Equity Ratio 0.00
Volume 6,485,500
Avg Vol 10,600,158
Day's Range N/A - N/A
Shares Out 390.58M
Stochastic %K 40%
Beta 2.01
Analysts Hold
Price Target $42.30

Company Profile

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and...

Industry: Biotechnology
Sector: Healthcare
Phone: 617 714 6500
Address:
325 Binney Street, Cambridge, United States
fastengels
fastengels Oct. 25 at 8:08 AM
$MRNA Downgrading of the banana republic https://www.reuters.com/business/scope-downgrades-us-credit-rating-public-finance-governance-deterioration-2025-10-24/
0 · Reply
ShortTrapSignal
ShortTrapSignal Oct. 24 at 9:58 PM
$NVAX 33.6% short float | 11 days to cover | 41% dark pool shorts 👀 Sanofi confirms Nuvaxovid sales surge 📈 The only non-mRNA vaccine tech with big pharma backing. Undervalued? Or next squeeze candidate? 🚀 “When 45M shares are short with 11DTC, the spark doesn’t need to be big to ignite a move 🔥” #NVAX #ShortSqueeze #HighShortInterest #BiotechStocks #ProteinBasedVaccine #Sanofi #VaccineStocks #Pharma #XBI #IBB #ARKG #NASDAQ #Pfizer #Moderna #Biontech #MomentumStocks #ShortCovering $MRNA, $PFE, $BNTX
0 · Reply
georgeyann
georgeyann Oct. 24 at 7:42 PM
$MRNA fake up before ER!
0 · Reply
fpak
fpak Oct. 24 at 7:26 PM
$MRNA Snorefest.
0 · Reply
BB_88_
BB_88_ Oct. 24 at 7:18 PM
$MRNA short 26.89 in to close
0 · Reply
zxxz
zxxz Oct. 24 at 7:18 PM
0 · Reply
NeverCapProfit
NeverCapProfit Oct. 24 at 5:08 PM
$MRNA month long handle, please move.
0 · Reply
fastengels
fastengels Oct. 24 at 4:25 PM
$MRNA Extremely Promising mRNA-1010 data https://irp.cdn-website.com/89dd0539/files/uploaded/Flu+mRNA-1010+P303+MN+Data+Poster+%281%29.pdf
0 · Reply
fastengels
fastengels Oct. 24 at 4:20 PM
$MRNA Moderna news https://www.medscape.com/viewarticle/no-signal-myocarditis-updated-moderna-mrna-covid-vaccine-2025a1000svq?form=fpf
1 · Reply
morganmueller23
morganmueller23 Oct. 24 at 3:12 PM
$MRNA — Vaccine profits funding R&D reinvention. $MRNA’s biotech pipeline may redefine future healthcare innovation.
0 · Reply
Latest News on MRNA
Moderna to Host Investor Event - Analyst Day

Oct 23, 2025, 7:00 AM EDT - 2 days ago

Moderna to Host Investor Event - Analyst Day


Moderna ends development of CMV vaccine after trial failure

Oct 22, 2025, 4:34 PM EDT - 2 days ago

Moderna ends development of CMV vaccine after trial failure


Moderna Vs BioNTech: Who's Winning The Post-COVID Race

Oct 18, 2025, 9:30 AM EDT - 6 days ago

Moderna Vs BioNTech: Who's Winning The Post-COVID Race

BNTX


Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript

Oct 17, 2025, 4:06 PM EDT - 7 days ago

Moderna, Inc. (MRNA) Shareholder/Analyst Call Transcript


3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 25 days ago

3 Of My Favorite Biotech Stocks Under $10

DVAX FOLD NUVB PFE


MRNA Stock vs. PFE & ALNY

Sep 15, 2025, 11:10 AM EDT - 5 weeks ago

MRNA Stock vs. PFE & ALNY


mRNA Biotechs - Long-Term Value Risks Abound

Aug 28, 2025, 6:20 AM EDT - 2 months ago

mRNA Biotechs - Long-Term Value Risks Abound

ALNY BNTX DHR GRAL ILMN IONS RGEN


30 Stocks That Could Rally 30% or More

Aug 25, 2025, 12:57 PM EDT - 2 months ago

30 Stocks That Could Rally 30% or More

ACN ADBE ALGN ARE CHTR CMG CRM


Moderna to Present at Upcoming Conferences in September 2025

Aug 21, 2025, 7:00 AM EDT - 2 months ago

Moderna to Present at Upcoming Conferences in September 2025


Moderna, Inc. (MRNA) Q2 2025 Earnings Call Transcript

Aug 1, 2025, 11:56 AM EDT - 3 months ago

Moderna, Inc. (MRNA) Q2 2025 Earnings Call Transcript


Moderna cuts 2025 revenue to $2.2B after UK booster delay

Aug 1, 2025, 10:11 AM EDT - 3 months ago

Moderna cuts 2025 revenue to $2.2B after UK booster delay


fastengels
fastengels Oct. 25 at 8:08 AM
$MRNA Downgrading of the banana republic https://www.reuters.com/business/scope-downgrades-us-credit-rating-public-finance-governance-deterioration-2025-10-24/
0 · Reply
ShortTrapSignal
ShortTrapSignal Oct. 24 at 9:58 PM
$NVAX 33.6% short float | 11 days to cover | 41% dark pool shorts 👀 Sanofi confirms Nuvaxovid sales surge 📈 The only non-mRNA vaccine tech with big pharma backing. Undervalued? Or next squeeze candidate? 🚀 “When 45M shares are short with 11DTC, the spark doesn’t need to be big to ignite a move 🔥” #NVAX #ShortSqueeze #HighShortInterest #BiotechStocks #ProteinBasedVaccine #Sanofi #VaccineStocks #Pharma #XBI #IBB #ARKG #NASDAQ #Pfizer #Moderna #Biontech #MomentumStocks #ShortCovering $MRNA, $PFE, $BNTX
0 · Reply
georgeyann
georgeyann Oct. 24 at 7:42 PM
$MRNA fake up before ER!
0 · Reply
fpak
fpak Oct. 24 at 7:26 PM
$MRNA Snorefest.
0 · Reply
BB_88_
BB_88_ Oct. 24 at 7:18 PM
$MRNA short 26.89 in to close
0 · Reply
zxxz
zxxz Oct. 24 at 7:18 PM
0 · Reply
NeverCapProfit
NeverCapProfit Oct. 24 at 5:08 PM
$MRNA month long handle, please move.
0 · Reply
fastengels
fastengels Oct. 24 at 4:25 PM
$MRNA Extremely Promising mRNA-1010 data https://irp.cdn-website.com/89dd0539/files/uploaded/Flu+mRNA-1010+P303+MN+Data+Poster+%281%29.pdf
0 · Reply
fastengels
fastengels Oct. 24 at 4:20 PM
$MRNA Moderna news https://www.medscape.com/viewarticle/no-signal-myocarditis-updated-moderna-mrna-covid-vaccine-2025a1000svq?form=fpf
1 · Reply
morganmueller23
morganmueller23 Oct. 24 at 3:12 PM
$MRNA — Vaccine profits funding R&D reinvention. $MRNA’s biotech pipeline may redefine future healthcare innovation.
0 · Reply
SPACE350PT
SPACE350PT Oct. 24 at 2:50 PM
$MRNA trump stake
0 · Reply
SPACE350PT
SPACE350PT Oct. 24 at 2:31 PM
$MRNA lets see 50
0 · Reply
taxplanr
taxplanr Oct. 24 at 2:31 PM
Using the bodies own mitochondria to combat cancers chronic illnesses and autoimmune diseases is what emf device companies like $ECOR can do Not failed malignantRNA platforms with toxic chemo does $BNTX $MRNA $BMY
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 24 at 12:40 PM
Enter: $MRNA NOV 14 2025 $27 CALLS Buy in Price: $1.88 - $2.00 Take Profit: $3.05 Stop Bleeding: $1.65 ROI Potential: 62% https://moneygroup.us/
0 · Reply
fpak
fpak Oct. 24 at 11:48 AM
$MRNA Awfully quiet on RFK's twitter account.... Either he is getting fired, or divorced.
1 · Reply
GladysFoster
GladysFoster Oct. 24 at 9:15 AM
$MRNA high
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Oct. 24 at 8:47 AM
$MRNA get rekt haters. LONG https://theconversation.com/covid-19-mrna-vaccines-could-unlock-the-next-revolution-in-cancer-treatment-new-research-258992
1 · Reply
taxplanr
taxplanr Oct. 24 at 3:25 AM
Gioblastoma tumors shrunk with no toxicity what could it be? Definitely not $BNTX $MRNA $PFE malignantRNA https://www.instagram.com/reel/DP9j8YIDb5p/?igsh=MThicTBld2UzNGQ2NA==
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 2:41 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $MRNA Current Share Price: $26.18 Contracts: $MRNA December 18, 2026 $28 Calls Scale in: $6.94- $8.49 Scale out: $10.80-$13.89 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
Ro_Patel
Ro_Patel Oct. 24 at 2:11 AM
What the what.... Preliminary research being reported in the journal Nature: People w/ advanced lung or skin cancer who were taking certain immunotherapy drugs lived substantially longer if they also got a $PFE or $MRNA shot within 100 days of starting treatment Vaccinated lung cancer patients were nearly twice as likely to be alive 3 years after beginning cancer treatment as the unvaccinated patients. The molecule that powers those specific vaccines, mRNA, appears to help the immune system respond better to the cutting-edge cancer treatment, concluded researchers Lead researcher: The vaccine “acts like a siren to activate immune cells throughout the body. We’re sensitizing immune-resistant tumors to immune therapy.” The research team found its results so promising that it is preparing a more rigorous study to see if mRNA coronavirus vaccines should be paired w/ cancer drugs called checkpoint inhibitors — an interim step while it designs new mRNA vaccines for use in cancer.
3 · Reply
taxplanr
taxplanr Oct. 24 at 12:36 AM
$BNTX $MRNA $PFE bioweapons just aren't vaccines and everyone is talking about it https://www.thekingstonreport.com/p/mrna-nanoparticle-technology-is-the?utm_source=post-email-title&publication_id=1103773&post_id=176944205&utm_campaign=email-post-title&isFreemail=false&r=18m8lm&triedRedirect=true&utm_medium=email
0 · Reply
shooshmonk
shooshmonk Oct. 23 at 11:03 PM
$MRNA I still think very strongly that Trump will get a 49%/51% stake in Moderna.
0 · Reply